阿尔蒂维昂 AORT
$20.21 −$5.12 (-20.21%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $20.21 0.00%
开盘$22.19
昨收$25.33
当日区间$19.74 – $23.01
成交量3.25M
市值$986.05M
市盈率（TTM）–
股息率–
AORT 相关新闻
匹配 Artivion 或代码 AORT 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $38 to $45
- Earnings Flash (AORT) Artivion, Inc. Posts Q2 Adjusted EPS $0.13 per Share, Vs. FactSet Est of $0.10
- CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $36
- CCORF Maintains Artivion(AORT.US) With Buy Rating, Raises Target Price to $40 正面
- CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $39
- Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $44
- Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
- Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
- A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48
- Lake Street Initiates Artivion(AORT.US) With Buy Rating, Announces Target Price $55
- Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $55
- Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX) 正面
- Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $58
- Ladenburg Thalmann Upgrades Artivion(AORT.US) to Buy Rating, Raises Target Price to $42 正面
- CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $48
暂无评论——快来第一个聊聊 AORT。